Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma

Zhao Hong-Xia; Sun Wan-Jun; Li Jie; Hu Hai-Lan; Ai Hui-Sheng

首页> 外文期刊>Leukemia and lymphoma >Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma

【24h】

Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma

机译：程序性单倍体造血干细胞输注结合全身化疗可改善难治性或复发性淋巴瘤患者的预后

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2015年第1期|共4页
作者
Zhao Hong-Xia; Sun Wan-Jun; Li Jie; Hu Hai-Lan; Ai Hui-Sheng;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma [J] . Zhao Hong-Xia, Sun Wan-Jun, Li Jie, Leukemia and lymphoma . 2015,第1期

机译：程序性单倍体造血干细胞输注结合全身化疗可改善难治性或复发性淋巴瘤患者的预后
2. Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature [J] . Zinzani P. L., Sasse S., Radford J., Critical reviews in oncology/hematology . 2015,第3期

机译：brentuximab vedotin在指定患者计划中的复发/难治性霍奇金淋巴瘤和复发/难治性系统间变性大细胞淋巴瘤的经验：文献综述
3. Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation [J] . Domingo-Domenech E., Boumendil A., Climent F., Bone marrow transplantation . 2020,第3期

机译：异种造血干细胞移植患者复发/难治性全身性血压大细胞淋巴瘤。欧洲血液移植淋巴瘤工作组的回顾性分析
4. Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome [C] . Philippe Saas, Beatrice Gaugler, Sylvain Perruche Conference on Clearance of Dying Cells in a Healthy and Diseased Immune System . 2010

机译：静脉内凋亡细胞输注作为基于细胞的治疗，从而改善造血细胞移植结果
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation [O] . Hejin Jia, Zhenguang Wang, Yao Wang, 2019

机译：单倍型造血干细胞移植后顽固性成年B-ALL复发和难治性成人B-ALL患者的单倍体CD19 / CD22双特异性CAR-T细胞诱导MRD阴性缓解
7. Corrigendum to ‘Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapsed Acute Leukemia’ Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319 [O] . Chen-Hua Yan, Qi-fa Liu, De-pei Wu, 2020

机译：“预防性供体淋巴细胞输注（DLI）之后的勘测和移植物与宿主疾病引导多种DLIS可以在难治性/复发急性白血病患者中改善同种异体造血干细胞移植后的结果血液和骨髓移植23的生物学23 / 8（2017）1311-1319

Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma

著录项

相似文献

相关主题

期刊订阅